Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • If you're over 60, drink up: Alcohol associated with better memory

  • New window of opportunity to prevent cardiovascular, diseases

  • Genes exhibit different behaviours in different stages of development

  • Human skin cells reprogrammed directly into brain cells

  • Bipolar disorder discovery at the nano level

  • Smoking interferes with neurocognitive recovery during abstinence from alcohol

  • Stress-related inflammation may increase risk for depression

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • Key factor in transition from moderate to problem drinking

  •